• SENSEX 78,890.97
    1,589.57 (+2.06%)
  • BANKNIFTY 55,913.60
    373.55 (+0.67%)
  • NSE
    1,850.00 1,878.00(%)
  • ITC
    277.30 252.80(%)
  • Tube Investments
    2,227.65 2,006.00(%)
  • Axis Bank
    1,274.70 1,418.30(%)
  • Reliance Industries
    1,325.00 1,611.20(%)
  • HDFC Life Insur.
    546.00 788.50(%)
  • Aurobindo Pharma
    1,748.85 1,739.95(%)
  • Lenskart Solut.
    767.40 725.00(%)
  • HDFC Bank
    762.80 1,017.90(%)
  • Titan Company
    4,858.90 5,187.45(%)
  • Petronet LNG
    320.00 326.40(%)
  • Jio Platforms
    1,442.00 1,490.00(%)
  • CG Power & Ind
    812.40 525.50(%)
  • Tonbo Imaging
    1,460.00 1,343.80(%)
  • Larsen & Toubro
    4,071.00 4,440.00(%)
  • Multi Comm. Exc.
    3,395.00 3,537.00(%)
  • Saregama India
    613.80 305.65(%)
  • Bajaj Finance
    1,055.80 1,177.60(%)
  • Cummins India
    4,036.95 3,883.30(%)
  • Bajaj Auto
    10,750.10 12,470.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sandu Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4291.0
  • ISIN : INE751D01014
35.23 -1 (-1.95%)
  • As on 05 Nov 2026 (EOD)

  • Today’s Low

    34.70

  • Today’s High

    36.50

  • Open

    36.50

  • Perv Close

    35.93

  • 52W Low

    30.00

  • 52W High

    50.00

Key Indicators

  • P/E(TTM)

    19.25

  • Mar.Cap (₹Cr.)

    34.04

  • Div & Yield %

    0.00

  • Book Value(₹)

    36.48

  • Debt-Equity Ratio

    -1.95

  • AGM Date

    04-Nov-2026

  • EPS

    1.83

  • P/E Ratio

    19.25

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    34.04

  • RONW (%)

    4.11

  • ROCE (%)

    5.98

Score Board

  • Equity (₹ in Cr.)

    9.66

  • BV (₹)

    36.50

  • Sales( ₹ in Cr.)

    69.93

  • NP (in Cr.)

    1.77

  • NP Var(%)

    14.0

  • Div%

    0.0

  • CPS (₹)

    2.50

  • EPS (₹)

    1.80

  • Traded Value (₹ in Lakhs)

    34.04

  • 52 Week High

    50.00

  • 52 Week Low

    30.00

  • Price BSE

    35.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    34.04

  • P/C Ratio

    13.80

  • P/E Ratio

    19.10

  • Price Vs.BV

    1.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 69.93 67.19 67.28 65.35 65.50 58.76
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 69.93 67.19 67.28 65.35 65.50 58.76
Other Income 0.44 0.17 0.42 0.33 0.08 0.19
Stock Adjustments -4.08 1.20 -1.63 3.08 0.45 -3.39
Total Income 66.29 68.56 66.07 68.76 66.03 55.56
EXPENDITURE :            
Raw Materials 27.49 33.30 30.94 34.27 36.20 31.11
Power and Fuel Cost 0.38 0.41 0.41 0.39 0.34 0.33
Employee Cost 10.69 10.92 10.07 11.10 8.91 8.02
Other Manufacturing Expenses 6.19 6.24 6.35 6.19 5.98 5.21
Selling and Administration Expenses 17.48 14.51 15.24 13.75 11.45 8.31
Miscellaneous Expenses 0.63 0.25 0.34 0.25 0.19 0.24
Employee Benefit Expenses 10.69 10.92 10.07 11.10 8.91 8.02
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 62.85 65.63 63.35 65.94 63.08 53.21
Operating Profit 3.44 2.93 2.72 2.82 2.96 2.35
Interest 0.11 0.10 0.06 0.08 0.11 0.11
Gross Profit 3.33 2.83 2.66 2.74 2.85 2.24
Depreciation 0.68 0.67 0.58 0.52 0.53 0.56
Profit Before Tax 2.65 2.16 2.08 2.22 2.32 1.68
Current Tax 0.79 0.59 0.59 0.66 0.70 0.56
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.10 0.02 0.02 0.03 0.03 0.03
Reported Net Profit 1.77 1.55 1.46 1.52 1.59 1.09
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 1.77 1.55 1.46 1.52 1.59 1.09
Adjustment below Net Profit 0.00 0.01 0.02 0.00 0.00 0.00
P & L Balance brought forward 9.52 8.59 7.70 6.68 4.97 3.27
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.63 0.62 0.59 0.51 -0.11 -0.61
P & L Balance carried down 10.66 9.52 8.59 7.70 6.68 4.97
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 8.00 8.00 0.00 7.50 5.00
Dividend Per Share(Rs) 0.00 0.80 0.80 0.00 0.75 0.50
Earnings Per Share-Unit Curr 1.83 1.60 1.51 1.58 1.80 1.38
Earnings Per Share(Adj)-Unit Curr 1.83 1.60 1.51 1.58 1.80 1.38
Book Value 36.48 34.62 33.01 40.62 30.71 29.63
Book Value(Adj)-Unit Curr 36.48 34.62 33.01 40.62 30.71 29.63

Shareholding Pattern

  • Promoter Group

    37.79%

  • Public Share Holding

    62.21%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,650,548 37.79 3,650,548 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,650,548 37.79 3,650,548 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 500 0.01 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 1,000 0.01 1,000 1
Venture Capital Funds 0 0.00 0 0
Sub total 1,500 0.02 1,000 2
2] Non Institution
Bodies Corporate 2,243,948 23.23 2,235,048 49
Clearing Members 9,140 0.09 9,140 6
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 15,535 0.16 15,535 34
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 125,312 1.30 125,012 102
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 766,895 7.94 766,895 10
Individuals holding nominal share capital up to Rs. 1 lakh 2,815,411 29.14 2,046,561 10,224
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 100 0.00 100 1
Others 8,100 0.08 5,600 3
Sub Total 6,008,942 62.20 5,228,392 10,433
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 9,660,990 100.00 8,879,940 10,441

Company Background

Sandu Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Sandu Pharmaceuticals Ltd
  • BSE Code : 4291.0
  • ISIN : INE751D01014

  • Incorporation Year

    1985

  • Registered Office

    Plot No 25/26/29 & 30
    Pilerne Indl Estate Marra Bard, Bardez,
    Goa-403511

  • Telephone

  • FAX

  • Chairman

    Balaram Vishwanathan

  • Managing Director

    Balaram Vishwanathan

  • Company Secretary

    Pratika Mhambray

  • Auditor

    Dileep & Prithvi

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Sharex Dynamic (India) Pvt Ltd
    C-101 247 Park ,
    L B S Marg ,Vikhroli West
    Mumbai - Mumbai - 400083

Sandu Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sandu Pharma. 35.23 70.38 69.93 19.25 7.96
Abbott India 27,146.85 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,365.10 2,304.07 2,275.58 93.81 27.86
Glaxosmi. Pharma 2,532.60 3,932.76 3,790.20 40.46 58.17
Evonile Pharma 1,736.60 393.10 354.33 43.85 15.94
Cipla 1,400.10 20,102.60 18,979.95 42.67 13.88
Bliss GVS Pharma 625.60 773.53 729.81 40.78 12.51
Amrutanjan Healt 511.45 520.13 502.55 27.39 24.16
Fermenta Biotec. 439.00 474.15 450.25 20.49 18.77
Guj. Themis Bio. 387.70 168.25 165.82 103.66 18.05
Ambalal Sarabhai 35.67 19.52 3.94 66.06 6.77